Mostafa Shokoohi

21PUBLICATIONS
88CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Ophthalmology and optometry not elsewhere classifiedNutrigenomics and personalised nutritionTransgender studies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Aug 07, 2026
A mortality model for relapsed or refractory multiple myeloma: emulation of subjective life expectancy criteria from a clinical trial in real-world data.

|Apr 01, 2026
Effectiveness of linvoseltamab versus real-world standard-of-care in triple-class-exposed relapsed/refractory multiple myeloma in the United States.

Shaji Kumar, Katja C Weisel, Paul Spin

|Mar 26, 2026
Linvoseltamab versus real-world International Myeloma Working Group standard-of-care in triple-class exposed relapsed/refractory multiple myeloma.

Shaji Kumar, Sundar Jagannath, Katja C Weisel

|Apr 30, 2025
Teprotumumab Improves Quality of Life in Thyroid Eye Disease: Meta-analysis and Matching-adjusted Indirect Comparison.

George J Kahaly, Ann Xi, Naina Barretto

|Aug 24, 2023
The Impact of a Digital Weight Loss Intervention on Health Care Resource Utilization and Costs Compared Between Users and Nonusers With Overweight and Obesity: Retrospective Analysis Study.

Ellen Siobhan Mitchell, Alexander Fabry, Annabell Suh Ho

|Aug 16, 2023
HIV prevalence among a retrospective clinical cohort of transgender women in Canada: Results of the Montreal-Toronto Trans study, collected 2018-2019.

Ashley Lacombe-Duncan, Yasmeen Persad, Mostafa Shokoohi

Pageof 4

Frequent Collaborators

5 joint publications

Mohammad Karamouzian

5 joint publications

Hamid Sharifi

3 joint publications

Christian Hampp

3 joint publications

Alexander Breskin